Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Segmental neurofibromatosis.

A Trattner1, M David, E Hodak

  • 1Department of Dermatology, Beilinson Medical Center, Petah Tiqva, Israel.

Journal of the American Academy of Dermatology
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pandemic of sensitivity to acrylate containing nail cosmetic among young Israeli women? Result of patch testing 2-hydroxyethyl methacrylate in the European baseline series.

Contact dermatitis·2024
Same author

The association between atopic dermatitis and inflammatory bowel disease in adults: A cross-sectional study in a specialized atopic dermatitis clinic.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Real-life experience of upadacitinib for the treatment of adult patients with moderate-to-severe atopic dermatitis - a case series.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Paediatric mycosis fungoides - characteristics, management and outcomes with particular focus on the folliculotropic variant.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Paediatric mycosis fungoides - characteristics, management and outcomes with particular focus on the folliculotropic variant.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Percutaneous ethanol sclerotherapy is a promising treatment for recalcitrant angiolymphoid hyperplasia with eosinophilia.

Clinical and experimental dermatology·2021
Same journal

Sexual function is missing from the adverse-effect map of GLP-1 receptor agonists in dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study.

Journal of the American Academy of Dermatology·2026
Same journal

Safety of Biologic Therapy in Psoriasis Patients With Malignancy.

Journal of the American Academy of Dermatology·2026
Same journal

Letter from the Editor: Glucagon-Like Peptide-1 (GLP-1) agonists in dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Rethinking the Occipital Scalp as a Control in Advanced Androgenetic Alopecia.

Journal of the American Academy of Dermatology·2026
Same journal

Parallel-Polarized Dermoscopy for Acral Parallel Pattern Analysis.

Journal of the American Academy of Dermatology·2026
See all related articles

Segmental neurofibromatosis, a rare skin condition, presents localized tumors without other systemic signs. This suggests it may be a distinct cutaneous hamartoma, separate from generalized neurofibromatosis.

Area of Science:

  • Dermatology
  • Medical Genetics

Background:

  • Neurofibromatosis encompasses a group of genetic disorders characterized by tumor formation on nerve cells.
  • Generalized neurofibromatosis types (NF1, NF2) present with widespread neurofibromas and potential systemic complications.

Observation:

  • Two patients presented with localized multiple cutaneous neurofibromas.
  • One patient exhibited bilateral scalp involvement, while the other displayed true segmental neurofibromatosis.
  • Crucially, no other systemic signs indicative of generalized neurofibromatosis were observed in either patient.

Findings:

  • The observed cases suggest a form of neurofibromatosis limited to specific body segments.
  • The absence of systemic manifestations differentiates these cases from classical neurofibromatosis.

Related Experiment Videos

Implications:

  • Segmental neurofibromatosis may represent a distinct entity, potentially a cutaneous hamartoma.
  • This distinction is critical for accurate diagnosis and management, differentiating it from more complex generalized forms.